Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins in ototoxicity
NCT06553157Phase 2Completed
- Sponsor
- Minia University
- Start
- Sep 2024
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ulinastatin in ototoxicity, sponsored by Minia University. Started Sep 2024; status: completed.
02
Drugs
ulinastatin
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT06553157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06553157.